These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19852983)

  • 21. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
    De Clercq E
    Med Res Rev; 2009 Jul; 29(4):611-45. PubMed ID: 19260077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In search of a selective antiviral chemotherapy.
    De Clercq E
    Clin Microbiol Rev; 1997 Oct; 10(4):674-93. PubMed ID: 9336668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yet another ten stories on antiviral drug discovery (part D): paradigms, paradoxes, and paraductions.
    De Clercq E
    Med Res Rev; 2010 Jul; 30(4):667-707. PubMed ID: 19626594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and managing the adverse effects of antiretroviral therapy.
    Hawkins T
    Antiviral Res; 2010 Jan; 85(1):201-9. PubMed ID: 19857521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dancing with chemical formulae of antivirals: a personal account.
    De Clercq E
    Biochem Pharmacol; 2013 Sep; 86(6):711-25. PubMed ID: 23876344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.
    Olivero OA
    Environ Mol Mutagen; 2007; 48(3-4):215-23. PubMed ID: 16395695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV reservoirs, latency, and reactivation: prospects for eradication.
    Dahl V; Josefsson L; Palmer S
    Antiviral Res; 2010 Jan; 85(1):286-94. PubMed ID: 19808057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
    Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E
    J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
    Naeger LK; Margot NA; Miller MD
    Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
    de Clercq E
    Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
    Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
    J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral acyclic nucleoside phosphonates structure activity studies.
    Holý A
    Antiviral Res; 2006 Sep; 71(2-3):248-53. PubMed ID: 16857275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging antiviral drugs.
    De Clercq E
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):393-416. PubMed ID: 18764719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapeutic approaches to human immunodeficiency virus infections.
    Baba M
    Fukushima J Med Sci; 1992 Jun; 38(1):1-18. PubMed ID: 1284048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to nucleoside and nucleotide analogues.
    Squires KE
    Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of antiviral agents: ten different compounds, ten different stories.
    De Clercq E
    Med Res Rev; 2008 Nov; 28(6):929-53. PubMed ID: 18438800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.
    Broder S
    Antiviral Res; 2010 Jan; 85(1):1-18. PubMed ID: 20018391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.